Market Tracker

06/22 8:23am ET

Novelion Therapeutics Inc (NASDAQ:NVLN)

3.63
Delayed Data
As of Jun 21
 -0.17 / -4.47%
Today’s Change
3.08
Today|||52-Week Range
10.68
+16.35%
Year-to-Date
No recent news for Novelion Therapeutics Inc.

Today’s Trading

Previous close3.80
Today’s open3.79
Day’s range3.60 - 3.89
Volume71,494
Average volume (3 months)42,412
Market cap$76.5M
Data as of 4:00pm ET, 06/21/2018

Growth & Valuation

Earnings growth (last year)-45.20%
Earnings growth (this year)+0.31%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)+919.88%
P/E ratioNM
Price/Sales0.42
Price/Book5.12

Competitors

 Today’s
change
Today’s
% change
CTSOCytosorbents Corp+0.15+1.38%
CDTXCidara Therapeutics ...-0.20-3.70%
CDXCChromadex Corp+0.15+4.34%
NATRNatures Sunshine Pro...+0.05+0.57%
Data as of 4:00pm ET, 06/21/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$138.4M
Annual profit (last year)-$126.7M
Net profit margin-91.53%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Operating Officer &
Executive VP
Jeffrey Hackman
Chief Financial Officer &
Senior Vice President
Michael Dennis Price
Corporate headquarters
Vancouver, British Columbia

Forecasts